Belgium· BE-AMP-SAM367157-00

Remifentanil Teva 1 mg

A remifentanil product containing remifentanil hydrochloride, registered in Belgium by Teva Pharma Belgium. The same ATC class is registered in 18 of our 19 countries.

ATC N01AH06

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about remifentanil hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Remifentanil is registered in 18 of 19 countries.

Countries holding a registration under ATC N01AH06 (remifentanil), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search remifentanil products by name

Remifentanil · ATC N01AH06

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of remifentanil costs, country by country.

Normalised to the WHO defined daily dose (52.5 mcg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Remifentanil · price per daily dose (52.5 mcg)

USD · FX 28 Sept 2026

FI Finland$0.30

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Remifentanil Hydrochloride
Manufacturer: Teva Pharma Belgium
Country: Belgium (BE)
ATC code: N01AH06
ATC class: Remifentanil
Defined daily dose: 52.5 mcg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
2777415
be_apb
0759605

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

123 interactions on record for remifentanil.

Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check remifentanil against other medicines How interaction checks work

Remifentanil · interactions on record

123 records

18 severe
91 moderate
14 info

Most severe, free to view

OndansetronA04AA01severe
GranisetronA04AA02severe
DolasetronA04AA04severe
PalonosetronA04AA05severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Remifentanil in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All remifentanil products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Remifentanil Hameln, Remifentanil Kabi
Bulgaria · Ремифентанил Хамелн, Ремифентанил-Чайкафарма
Cyprus · Refenta
Czechia · Remifentanil B. Braun
Germany · Remifentanil B. Braun, Remifentanil Genmed
Denmark · Remifentanil B. Braun, Remifentanil Fresenius Kabi
Estonia · Remifentanil Kabi
Spain · Remifentanilo Kern Pharma, Remifentanilo Noridem
Finland · Remifentanil, Remifentanil B. Braun
France · Remifentanil Piramal, Remifentanil Viatris
United Kingdom (Northern Ireland) · Remifentanil, Remifentanil B. Braun
Greece · Dormiden, Remifentanil Anfarm
Croatia · Remifentanil Hameln
Ireland · Remifentanil, Remifentanil Fresenius Kabi Deutschland
Iceland · Remifentanil Hameln
Italy · Remifentanil Hameln, Remifentanil Mylan Generics
Lithuania · Remifentanil Kabi
Luxembourg · Ultiva
Latvia · Remifentanil Kabi
Malta · Remifentanil Anfarm, Remifentanil Noridem
Netherlands · Remifentanil B. Braun, Remifentanil Fresenius Kabi
Norway · Remifentanil Hameln, Remifentanil Orion
Poland · Ultiva
Portugal · Remifentanilo Accord, Remifentanilo Asklepius
Romania · Remifentanil Kabi
Sweden · Remifentanil B. Braun, Remifentanil Hameln
Slovenia · Remifentanil Hameln
Slovakia · Remifentanil B. Braun, Ultiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b302ebc1-6dfb-4fdb-b576-0cc734f71a67
GET /v1/drugs/b302ebc1-6dfb-4fdb-b576-0cc734f71a67?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for concentrate for solution for injection/infusion",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Remifentanil Teva 1 mg",
  "name_fr": "Remifentanil Teva 1 mg",
  "name_nl": "Remifentanil Teva 1 mg",
  "amp_code": "SAM367157-00",
  "strengths": [
    "1.1000",
    "1.1000",
    "1.0000",
    "1.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Remifentanil Hydrochloride",
    "Remifentanil"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Remifentanil",
  "authorisation_numbers": [
    "BE367157"
  ]
}

API reference MCP server Plans

See everything about remifentanil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console